Medical Science Liaison Dermatology - Northeast

Key Responsibilities

• Clinical Support
• Collaborate with the clinical study teams to provide medical and scientific support for clinical sites
• Key Opinion Leader (KOL) Engagement:
• Develop and maintain strong relationships with clinical study investigators, key opinion leaders, and other external stakeholders in the field of dermatology
• Act as a credible, scientific resource for KOLs, providing them with up-to-date and relevant information on Apogee’s development programs
• Stay abreast of the latest developments, publications, and research in dermatology to effectively communicate with experts in the field
• Stay informed of competitor products and market trends in dermatology

Internal Collaboration

• Work closely with cross-functional teams, including Medical Affairs, Clinical Development, Clinical Operations, and Business Development & Strategy to ensure strategic alignment
• Provide insights and feedback to internal teams based on interactions with external stakeholders

Ideal Candidate

• MSL : 2+ years relevant experience as outlined below
• Sr. MSL: 5+ years relevant experience as outlined below. In addition to the ideal MSL criteria outlined below, a Senior MSL candidate would bring established KOL relationships, demonstrated strategic territory engagement planning, experience supporting clinical trials, and a track record of leading multiple projects and congress initiatives. They would also serve as a peer leader and mentor, and exhibit intentional, cross-functional collaboration.
• Advanced degree in a relevant medical or scientific field (MD/DO, PharmD, PhD, MS or equivalent)
• Expertise in medical dermatology, specifically, atopic dermatitis preferred
• Strong understanding of clinical study execution and appropriate interactions with clinical study sites
• Knowledge of compliance requirements related to medical affairs activities and appropriate interactions with healthcare professionals
• Knowledge of the dermatology therapeutic area and current treatment paradigms in inf